Stifel Canada analysts adjusted their stance on Medexus Pharma (MDP:CN) (OTC: PDDPF), downgrading the stock rating from Buy to Hold and reducing the price target to Cdn$3.45 from the previous Cdn$6.00 ...

Cantor Fitzgerald reaffirmed its Overweight rating on Neurocrine Biosciences stock (NASDAQ:NBIX) with a consistent price target of $170.00. Currently trading at $150.51, the stock has shown strong ...

Hundreds of millions of dollars have been paid in cases involving 3 ex-cops: Jon Burge, Reynaldo Guevara and Ronald Watts. And more than 220 lawsuits are still pending. Beleaguered taxpayers might end ...

Gov. Janet Mills' proposal to set a new tax on prescription drugs is drawing widespread criticism from the industry, which ...

Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to increase its ...

BridgeBio could be an acquisition target, but current financial challenges and competition suggest a "Hold" rating until ...

A Maryland mom got diagnosed with a condition she didn’t know she had. Then she couldn’t afford the medicine. Now, state ...

Sigma has recently consolidated a number of regional warehouses but still has excess warehouse capacity. While this leaves significant space for growth without further investment, and it is the ...

Drivers waiting at a McDonald’s drive-thru got a dinner and a show when a police officer on horse back dramatically chased a ...

The Medicare $2 Drug List Model included generic drugs for high blood pressure, diabetes and other ailments many elderly face ...

The drug manufacturers and hospitals say that the cost of medicine will rise due to the tariff and there could be an impact ...

Why, Naroff asks, would the White House upend the international trade structure by going after our closest trading partners?